Difference between revisions of "Yu D, et al. Lab. Invest. (2014) cited as Ref 351 in DOI: 10.1038/s41392-020-0110-5 (Q9614)"

From Wikibase.slis.ua.edu
Jump to navigation Jump to search
(‎Created claim: Volume (P103): 94, #quickstatements; #temporary_batch_1590009084631)
(‎Created claim: title (P93): miR-106b modulates cancer stem cell characteristics through TGF-beta/Smad signaling in CD44-positive gastric cancer cells, #quickstatements; #temporary_batch_1590010982689)
Property / title
 +
miR-106b modulates cancer stem cell characteristics through TGF-beta/Smad signaling in CD44-positive gastric cancer cells (English)
Property / title: miR-106b modulates cancer stem cell characteristics through TGF-beta/Smad signaling in CD44-positive gastric cancer cells (English) / rank
 +
Normal rank

Revision as of 21:59, 20 May 2020

Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
Language Label Description Also known as
English
Yu D, et al. Lab. Invest. (2014) cited as Ref 351 in DOI: 10.1038/s41392-020-0110-5
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8

    Statements

    Yu D
    0 references
    Shin HS
    0 references
    Lee YS
    0 references
    0 references
    2014
    0 references
    Lab. Invest.
    0 references
    94
    0 references
    miR-106b modulates cancer stem cell characteristics through TGF-beta/Smad signaling in CD44-positive gastric cancer cells (English)
    0 references